81 FR 63219 - Bulk Manufacturer of Controlled Substances Application: Alcami Wisconsin Corporation
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 81, Issue 178 (September 14, 2016)
Drug Enforcement Administration
Federal Register Volume 81, Issue 178 (September 14, 2016)
| Page Range | 63219-63219 | |
| FR Document | 2016-22100 |
[Federal Register Volume 81, Number 178 (Wednesday, September 14, 2016)] [Notices] [Page 63219] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-22100] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Bulk Manufacturer of Controlled Substances Application: Alcami Wisconsin Corporation ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before November 14, 2016. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated her authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (``Deputy Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on November 18, 2015, Alcami Wisconsin Corporation, W130 N10497 Washington Drive, Germantown, Wisconsin 53022 applied to be registered as a bulk manufacturer of alfentanil (9737), a basic class of controlled substance listed in schedule II. The company plans to manufacture reference standards for distribution to their research and forensic customers. Dated: September 7, 2016. Louis J. Milione, Deputy Assistant Administrator. [FR Doc. 2016-22100 Filed 9-13-16; 8:45 am] BILLING CODE 4410-09-P
![Federal Register / Vol. 81, No. 178 / Wednesday, September 14, 2016 / Notices 63219
to which the United States is a party compliance, and to punish violations of Substances Act to the Administrator of
(including grand jury proceedings), or its provisions. the Drug Enforcement Administration
for the purpose of securing compliance (DEA), 28 CFR 0.100(b). Authority to
XIII. Expiration of Final Judgment
with this Final Judgment, or as exercise all necessary functions with
otherwise required by law. Unless this Court grants an extension, respect to the promulgation and
D. If at the time information or this Final Judgment shall expire ten implementation of 21 CFR part 1301,
documents are furnished by Defendants years from the date of its entry. incident to the registration of
to the United States, Defendants XIV. Public Interest Determination manufacturers, distributors, dispensers,
represent and identify in writing the importers, and exporters of controlled
material in any such information or Entry of this Final Judgment is in the substances (other than final orders in
documents to which a claim of public interest. The parties have connection with suspension, denial, or
protection may be asserted under Rule complied with the requirements of the revocation of registration) has been
26(c)(1)(G) of the Federal Rules of Civil Antitrust Procedures and Penalties Act, redelegated to the Deputy Assistant
Procedure, and Defendants mark each 15 U.S.C § 16, including making copies Administrator of the DEA Office of
pertinent page of such material, available to the public of this Final Diversion Control (‘‘Deputy Assistant
‘‘Subject to claim of protection under Judgment, the Competitive Impact Administrator’’) pursuant to section 7 of
Rule 26(c)(1)(G) of the Federal Rules of Statement, and any comments thereon, 28 CFR part 0, appendix to subpart R.
Civil Procedure,’’ then the United States and the United States’ responses to In accordance with 21 CFR
shall give Defendants ten (10) calendar comments. Based upon the record 1301.33(a), this is notice that on
days notice prior to divulging such before the Court, which includes the November 18, 2015, Alcami Wisconsin
material in any legal proceeding (other Competitive Impact Statement and any Corporation, W130 N10497 Washington
than a grand jury proceeding). comments and response to comments Drive, Germantown, Wisconsin 53022
filed with the Court, entry of this Final applied to be registered as a bulk
XI. No Reacquisition and Other Judgment is in the public interest.
Prohibited Activities manufacturer of alfentanil (9737), a
Date: llllllllllllllllll basic class of controlled substance listed
Defendants may not (1) reacquire any
Court approval subject to procedures of in schedule II.
part of the Divestiture Assets, (2) Antitrust Procedures and Penalties Act, 15 The company plans to manufacture
acquire any option to reacquire any part U.S.C. § 16
of the Divestiture Assets or to assign the reference standards for distribution to
lllllllllllllllllllll their research and forensic customers.
Divestiture Assets to any other person,
United States District Judge. Dated: September 7, 2016.
(3) enter into any local marketing
agreement, joint sales agreement, other [FR Doc. 2016–22086 Filed 9–13–16; 8:45 am] Louis J. Milione,
cooperative selling arrangement, or BILLING CODE P Deputy Assistant Administrator.
shared services agreement, or conduct [FR Doc. 2016–22100 Filed 9–13–16; 8:45 am]
other business negotiations jointly with BILLING CODE 4410–09–P
the Acquirers with respect to the DEPARTMENT OF JUSTICE
Divestiture Assets, or (4) provide
financing or guarantees of financing Drug Enforcement Administration
DEPARTMENT OF JUSTICE
with respect to the Divestiture Assets, [Docket No. DEA–392]
during the term of this Final Judgment. Drug Enforcement Administration
The shared services prohibition does Bulk Manufacturer of Controlled
not preclude Defendants from Substances Application: Alcami [Docket No. DEA–392]
continuing or entering into agreements Wisconsin Corporation
in a form customarily used in the Bulk Manufacturer of Controlled
ACTION: Notice of application.
industry to (1) share news helicopters or Substances Registration
(2) pool generic video footage that does DATES: Registered bulk manufacturers of
not include recording a reporter or other ACTION: Notice of registration.
the affected basic classes, and
on-air talent, and does not preclude applicants therefore, may file written
Defendants from entering into any non- SUMMARY: Registrants listed below have
comments on or objections to the applied for and been granted
sales-related shared services agreement issuance of the proposed registration in
or transition services agreement that is registration by the Drug Enforcement
accordance with 21 CFR 1301.33(a) on Administration (DEA) as bulk
approved in advance by the United or before November 14, 2016.
States in its sole discretion. manufacturers of various classes of
ADDRESSES: Written comments should controlled substances.
XII. Retention of Jurisdiction be sent to: Drug Enforcement SUPPLEMENTARY INFORMATION: The
This Court retains jurisdiction to Administration, Attention: DEA Federal companies listed below applied to be
enable any party to this Final Judgment Register Representative/ODW, 8701 registered as manufacturers of various
to apply to this Court at any time for Morrissette Drive, Springfield, Virginia basic classes of controlled substances.
further orders and directions as may be 22152. Information on previously published
necessary or appropriate to carry out or SUPPLEMENTARY INFORMATION: The notices is listed in the table below. No
construe this Final Judgment, to modify Attorney General has delegated her comments or objections were submitted
asabaliauskas on DSK3SPTVN1PROD with NOTICES
any of its provisions, to enforce authority under the Controlled for these notices.
Company FR Docket Published
Johnson Matthey, Inc .............................................................................................................. 81 FR 3475 ............................ January 21, 2016.
Mallinckrodt, LLC ..................................................................................................................... 81 FR 31959 .......................... May 20, 2016.
American Radiolabeled Chemicals .......................................................................................... 81 FR 31960 .......................... May 20, 2016.
Rhodes Technologies .............................................................................................................. 81 FR 34371 .......................... May 31, 2016.
VerDate Sep<11>2014 20:55 Sep 13, 2016 Jkt 238001 PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 E:\FR\FM\14SEN1.SGM 14SEN1](https://thefederalregister.org/doc/81_FR_63397/page/1.svg)
Document Created: 2016-09-14 02:27:24
Document Modified: 2016-09-14 02:27:24
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before November 14, 2016. | |
| FR Citation | 81 FR 63219 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR